IBMINTERNATIONAL BUSINESS MACH...

NYSE ibm.com


$ 167.15 $ 0.88 (0.53 %)    

Friday, 10-May-2024 15:59:52 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 167.15
$ 166.90
$ 0.00 x 0
$ 0.00 x 0
$ 166.34 - $ 168.05
$ 115.63 - $ 197.22
2,255,370
na
156.02B
$ 0.83
$ 19.07
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 10-31-2023 09-30-2023 10-Q
4 07-25-2023 06-30-2023 10-Q
5 04-25-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 10-25-2022 09-30-2022 10-Q
8 07-25-2022 06-30-2022 10-Q
9 04-26-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 07-27-2021 06-30-2021 10-Q
13 04-27-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 10-27-2020 09-30-2020 10-Q
16 07-28-2020 06-30-2020 10-Q
17 04-28-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 07-30-2019 06-30-2019 10-Q
21 04-30-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 07-31-2018 06-30-2018 10-Q
25 04-24-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-25-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 10-25-2016 09-30-2016 10-Q
32 07-26-2016 06-30-2016 10-Q
33 04-26-2016 03-31-2016 10-Q
34 02-23-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-28-2015 06-30-2015 10-Q
37 04-28-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-29-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 from-hype-to-reality-ai-reshapes-pharmaceutical-industry-across-drug-discovery-to-marketing---stocks-to-watch

Unlock the potential of AI in pharmaceuticals. With AI's help, the pharma industry could see $60B-$110B in annual economic ...

Core News & Articles

New Value Generation partnership initiative focused on delivering greater client productivity and innovation with new generativ...

 exane-bnp-paribas-initiates-coverage-on-ibm-with-underperform-rating-announces-price-target-of-145

Exane BNP Paribas analyst Stefan Slowinski initiates coverage on IBM (NYSE:IBM) with a Underperform rating and announces Pri...

 ibm-emerges-victorious-in-16b-legal-battle-report

IBM secures legal victory, saving $1.6 billion in damages awarded to BMC Software Inc. The U.S. 5th Circuit Court of Appeals ru...

 ibm-board-approves-increase-in-quarterly-cash-dividend-from-166-to-167-per-share

The IBM (NYSE:IBM) board of directors today declared an increase in the regular quarterly cash dividend to $1.67 per common sha...

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 morgan-stanley-maintains-equal-weight-on-ibm-lowers-price-target-to-179

Morgan Stanley analyst Erik Woodring maintains IBM (NYSE:IBM) with a Equal-Weight and lowers the price target from $186 to $...

 whats-going-on-with-ibm-stock-amid-expansion-in-canada

IBM announced agreements with the Canadian government to develop semiconductor capabilities, despite positive remarks from Prim...

Core News & Articles

Up to $187M CAD to be invested to progress expansion of chip packaging capacity and capabilities and to strengthen R&D at I...

 jp-morgan-maintains-neutral-on-ibm-lowers-price-target-to-185

JP Morgan analyst Brian Essex maintains IBM (NYSE:IBM) with a Neutral and lowers the price target from $190 to $185.

 stocks-drop-tech-tumbles-with-metas-weak-outlook-q1-stagflation-fears-gold-miners-advance-whats-driving-markets-thursday

Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NA...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION